Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 481 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

PharmaTher Announces FDA Acceptance, As a Priority Original Abbreviated New Drug Application, for KETARX™ (Ketamine)

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  PharmaTher Holdings Ltd.

SciSparc Announces Expected Implementation of 1-for-26 Reverse Share Split

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  SciSparc Ltd.

Vaccinex to Present Update on PDAC/Pepinemab Study; New ActivMAb® Application

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Vaccinex, Inc

Cidara Therapeutics to Present New Data on Novel drug-Fc conjugate CD388 at IDWeek 2023

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Cidara Therapeutics, Inc.

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Attention and Working Memory in Patients with Post Traumatic Stress Disorder (PTSD)

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  electroCore, Inc.

BrainsWay Announces Presentation of Two Deep TMS™ Posters at Upcoming World Congress of Psychiatry

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Brainsway Ltd.

LifeMD to Participate in Two Investor Conferences in October

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  LifeMD, Inc

STRATA Skin Sciences to Present at Upcoming October Conferences

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  STRATA Skin Sciences, Inc.

Arcutis Appoints L. Todd Edwards as Chief Commercial Officer

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Arcutis Biotherapeutics, Inc.

Teknova Launches Latest Proprietary AAV-Tek™ Product and End-to-End Plasmid Workflow Solutions to Streamline Therapeutic Process Development

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Teknova

Femasys Inc. Expands FemBloc Pivotal Trial Enrollment Securing First Academic Site to Participate

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Femasys Inc.

Amolyt Pharma to Present Data on the Renal Effects of Eneboparatide, a PTHR1 Agonist in Phase 3 for the Treatment of Hypoparathyroidism, at the 39th Congress of the French Society of Endocrinology

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Amolyt Pharma SAS

Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2023

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Daxor Corporation

Verrica Pharmaceuticals to Host Virtual KOL Event Discussing the Approval of YCANTH™ (Cantharidin) Topical Solution for the Treatment of Molluscum on October 11, 2023

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Verrica Pharmaceuticals Inc.

Akari Therapeutics to Present at Emerging Growth Conference

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Akari Therapeutics Plc

IBA finalizes contract with Medtechnica Ltd for two Proteus®ONE proton therapy solutions at the Tel Aviv Sourasky Medical Center in Israel  

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Ion Beam Applications S.A. (IBA)

Medigene AG Secures European Patent for its PD1-41BB Costimulatory Switch Protein

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Medigene AG

Ocuphire Pharma and Viatris Announce FDA Approval of RYZUMVI™ (Phentolamine Ophthalmic Solution) 0.75% Eye Drops for the Treatment of Pharmacologically-Induced Mydriasis Produced by Adrenergic Agonists (e.g., Phenylephrine) or Parasympatholytic (e.g.

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Ocuphire Pharma, Inc.

Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Mainz Biomed N.V.

Gracell Biotechnologies Reports Updated Clinical Data for FasTCAR-T GC012F for High-Risk, Newly Diagnosed Multiple Myeloma, Demonstrating 100% Stringent Complete Response Rate

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Gracell Biotechnology Ltd.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑